Albert Alhatem

410 total citations
30 papers, 277 citations indexed

About

Albert Alhatem is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, Albert Alhatem has authored 30 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Epidemiology and 6 papers in Dermatology. Recurrent topics in Albert Alhatem's work include Sarcoma Diagnosis and Treatment (4 papers), Nail Diseases and Treatments (3 papers) and Cancer and Skin Lesions (3 papers). Albert Alhatem is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Nail Diseases and Treatments (3 papers) and Cancer and Skin Lesions (3 papers). Albert Alhatem collaborates with scholars based in United States, Netherlands and Australia. Albert Alhatem's co-authors include Bernardo M. Cavalcanti, Pedram Hamrah, W. Clark Lambert, Robert A. Schwartz, Debra S. Heller, Chen Liu, Ravi J. Chokshi, Sara Behbahani, Indira Neeli and Steve Charles and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and British Journal of Dermatology.

In The Last Decade

Albert Alhatem

29 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Alhatem United States 9 100 73 65 54 46 30 277
Elif Betül Türkoğlu Türkiye 11 69 0.7× 195 2.7× 49 0.8× 110 2.0× 30 0.7× 38 350
S Moretti Italy 9 90 0.9× 63 0.9× 65 1.0× 53 1.0× 41 0.9× 22 450
Matthew Lee-Wing Canada 9 49 0.5× 109 1.5× 54 0.8× 25 0.5× 24 0.5× 14 288
Mualla Polat Türkiye 11 41 0.4× 58 0.8× 39 0.6× 13 0.2× 48 1.0× 36 374
H. Spelsberg Germany 12 161 1.6× 173 2.4× 34 0.5× 274 5.1× 39 0.8× 25 405
Everette Jacob Remington Nelson India 10 77 0.8× 62 0.8× 13 0.2× 94 1.7× 34 0.7× 21 282
Praneetha Thulasi United States 11 133 1.3× 243 3.3× 104 1.6× 164 3.0× 34 0.7× 25 513
J M McCarthy Canada 8 27 0.3× 88 1.2× 35 0.5× 62 1.1× 109 2.4× 16 283
Toktam Shahraki Iran 11 96 1.0× 234 3.2× 14 0.2× 158 2.9× 28 0.6× 22 386

Countries citing papers authored by Albert Alhatem

Since Specialization
Citations

This map shows the geographic impact of Albert Alhatem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Alhatem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Alhatem more than expected).

Fields of papers citing papers by Albert Alhatem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Alhatem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Alhatem. The network helps show where Albert Alhatem may publish in the future.

Co-authorship network of co-authors of Albert Alhatem

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Alhatem. A scholar is included among the top collaborators of Albert Alhatem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Alhatem. Albert Alhatem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alhatem, Albert, et al.. (2024). Revolutionizing diagnostic pathology: The emergence and impact of artificial intelligence—what doesn't kill you makes you stronger?. Clinics in Dermatology. 42(3). 268–274. 3 indexed citations
2.
Hanson, Jamie L., et al.. (2023). Dupilumab-associated mycosis fungoides: a cross-sectional study. Archives of Dermatological Research. 315(9). 2561–2569. 11 indexed citations
3.
Hanson, Jamie L., et al.. (2023). Dupilumab-Associated Sezary Syndrome. Indian Journal of Dermatology. 68(4). 459–462. 1 indexed citations
4.
Alhatem, Albert, et al.. (2022). Type III cutaneous atypical meningioma of the scalp. Journal of Cutaneous Pathology. 49(6). 565–569. 1 indexed citations
5.
Schwartz, Robert A., et al.. (2022). To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma. Archives of Dermatological Research. 315(4). 903–915. 4 indexed citations
6.
Alhatem, Albert, et al.. (2022). Primary Cutaneous Blastomycosis. New England Journal of Medicine. 386(18). e49–e49. 3 indexed citations
7.
8.
Alhatem, Albert, et al.. (2020). Granuloma Annulare – A Manifestation of Primary Cutaneous Mucinous Carcinoma?. Cureus. 12(12). e12304–e12304. 1 indexed citations
9.
Alhatem, Albert, et al.. (2020). Impact of partnership status on clinical outcomes of patients with vulvar squamous cell carcinoma and performance of sentinel lymph node biopsy. International Journal of Gynecological Cancer. 30(5). 583–589. 5 indexed citations
10.
Lambert, W. Clark, Albert Alhatem, Muriel W. Lambert, & Robert A. Schwartz. (2020). What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside. Clinics in Dermatology. 39(1). 107–117. 2 indexed citations
11.
Alhatem, Albert, Odette Spruijt, Debra S. Heller, et al.. (2020). “Do-not-resuscitate (DNR)” status determines mortality in patients with COVID-19. Clinics in Dermatology. 39(3). 510–516. 13 indexed citations
12.
Alhatem, Albert, et al.. (2020). Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma. Cancer Epidemiology. 67. 101723–101723. 9 indexed citations
13.
Alhatem, Albert, et al.. (2020). Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database. Journal of Surgical Research. 259. 62–70. 8 indexed citations
14.
Alhatem, Albert, et al.. (2020). Dermatopathologic Signs of Systemic Disease I: Acquired Perforating Dermatosis and Kyrle Disease.. SKINmed Dermatology for the Clinician. 18(5). 301–303. 2 indexed citations
15.
Alhatem, Albert, et al.. (2020). Percutaneous Route of Life: Chylothorax or Total Parenteral Nutrition-Related Bilateral Pleural Effusion in a Neonate?. Fetal and Pediatric Pathology. 40(5). 505–510. 4 indexed citations
16.
Singer, Steven R., et al.. (2019). Maxillary ameloblastoma in an 8-year-old child: A case report with a review of the literature. Imaging Science in Dentistry. 49(3). 241–241. 2 indexed citations
17.
Behbahani, Sara, et al.. (2019). The pathophysiology of pityriasis alba: Time-dependent histologic changes. Clinics in Dermatology. 38(3). 354–356. 2 indexed citations
18.
Alhatem, Albert & Donghong Cai. (2019). Behind the Skin: A Rare Case of Scurvy-Associated Megaloblastic Anemia. Clinical Medicine Insights Case Reports. 12. 3571479372–3571479372. 1 indexed citations
19.
Iannaccone, Alessandro, Francesco Giorgianni, TJ Hollingsworth, et al.. (2015). Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis. PLoS ONE. 10(12). e0145323–e0145323. 47 indexed citations
20.
Alhatem, Albert, Bernardo M. Cavalcanti, & Pedram Hamrah. (2012). In Vivo Confocal Microscopy in Dry Eye Disease and Related Conditions. Seminars in Ophthalmology. 27(5-6). 138–148. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026